Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19

INTRODUCTION: Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury have been reported. Scant data are available on the use and safety of remdesivir i...

Descripción completa

Detalles Bibliográficos
Autores principales: Buxeda, Anna, Arias-Cabrales, Carlos, Pérez-Sáez, María José, Cacho, Judit, Cabello Pelegrin, Sheila, Melilli, Edoardo, Aladrén, María José, Galeano, Cristina, Lorenzo, Inmaculada, Mazuecos, Auxiliadora, Saura, Isabel María, Franco, Antonio, Ruiz-Fuentes, María del Carmen, Sánchez-Cámara, Luis Alberto, Siverio, Orlando, Martin, María Luisa, González-García, Elena, López, Verónica, Martin-Moreno, Paloma Leticia, Moina, Iñigo, Moral Berrio, Esperanza, Moreso, Francesc, Portolés, José María, Santana-Estupiñán, Raquel, Zárraga, Sofía, Canal, Cristina, Sánchez-Álvarez, Emilio, Pascual, Julio, Crespo, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257403/
https://www.ncbi.nlm.nih.gov/pubmed/34250317
http://dx.doi.org/10.1016/j.ekir.2021.06.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257403/
https://www.ncbi.nlm.nih.gov/pubmed/34250317
http://dx.doi.org/10.1016/j.ekir.2021.06.023

Ejemplares similares